Exploring the role of reversible biological acetylation in health and disease
Official title: Reversible Biological Acetylation in Health and Disease
Funded at Federation of Amer Soc for Exper Biology · NIH-10897361 · Data updated 2026-11-12
This study is all about a conference where scientists gather to share the latest discoveries about a process called reversible biological acetylation, which affects how proteins work and is connected to diseases like cancer, with the hope that their findings will lead to better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Federation of Amer Soc for Exper Biology NIH-funded |
| Lab location | 1 site (Rockville, UNITED STATES) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $15,000 |
| NIH project number | 1R13CA290701-01 |
| Project ID | NIH-10897361 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with conditions related to cancer or metabolic disorders may be ideal candidates to benefit from the findings of this research.
✕Less likely to help
Patients with unrelated health issues or those not affected by conditions influenced by acetylation may not receive direct benefits from this research.
What this research studies
This research focuses on a conference that brings together scientists from various fields to discuss the latest findings related to reversible biological acetylation, a process that affects protein function and is linked to diseases such as cancer. Attendees will explore topics including the mechanisms of acetylation, its role in metabolism, and its implications for aging and development. The conference aims to foster collaboration and share innovative approaches in the study of acetylation and its potential therapeutic applications. Patients may benefit indirectly through advancements in understanding and treatment of conditions related to acetylation.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases influenced by acetylation, particularly cancer.
How similar studies have gone: Previous conferences and research in the field of acetylation have shown promising results, indicating a growing understanding of its biological significance.
Where this research is happening
-
Federation of Amer Soc for Exper Biology
Rockville, United States Active
Researchers
- Principal investigator: Dou, Yali — Federation of Amer Soc for Exper Biology
- Study coordinator: Dou, Yali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.